Modernizing Septoplasty

The only minimally invasive, cartilage-preserving septoplasty option for all cartilaginous deviations.

Modernizing Septoplasty

The only minimally invasive cartilage-preserving septoplasty treatment for all cartilaginous deviations.

Why SEPTALIGN

Septoplasty has remained largely unchanged since 1937. Until Today.

Patients are searching for a minimally invasive, patient-friendly alternative to surgical septoplasty that provides fast symptom relief, shorter post-operative downtime and doesn’t destabilize the nose.  

Meet SeptAlign - the first minimally invasive, clinically proven septoplasty option that reduces downtime and recovery. 

Diagram of the human nose and nasal cavity showing the structure of the nasal passages and sinuses.
Diagram of the human nose and nasal cavity showing the structure of the nasal passages and sinuses. 
simplifying Septoplasty

Unlike traditional surgical approaches, SeptAlign does not involve removing, morselizing, or scoring the septal cartilage to correct the deviation.

SeptAlign uses a bioresorbable implant that acts like a temporary brace to straighten the septum. The implant holds the septum in its new position, allowing the cartilage to remodel over time, providing durable, long-term correction of the deviation. The implant dissolves within 6 months, leaving nothing behind but a straightened septum.

how it works

Straighten

Corrects the deviation with an easy-to-place, bioresorbable polydioxanone (PDO) implant that resorbs within 6 months.

Stabilize

Maintains an open nasal airway as the cartilage heals in its corrected position.

Preserve

Maintains the existing anatomical strength and structural integrity of the septum, without removing cartilage.

CLINICALLY PROVEN

Minimally Invasive. Clinically Effective.

The multi-center, multi-cohort Vayu Study¹ (n=75) evaluated the safety and effectiveness of the FDA-cleared SeptAlign as a stand-alone septoplasty treatment, with and without inferior turbinate reduction. 

Excellent NOSE Scores

>60% reduction in NOSE Scores sustained through 12 months.

Excellent Safety Profile

No serious adverse device events and no unanticipated adverse events.

Real-World Patients

~45% of patients had a severe or extreme airway narrowing.²

  1. Data on file.

  2. Sub analysis of n=30 patients treated with SeptAlign in the Vayu Study where investigators collected morphological data on septal deviation. Data on file.

PATIENT-FRIENDLY RESULTS

High Satisfaction. Minimal Impact on Daily Life.

The Vayu Study¹ results evaluating SeptAlign as a stand-alone treatment — with or without inferior turbinate reduction — showed: 

Patient Recommended

97% of patients would recommend the procedure to a friend or family member.

Return to Work

One-day median time to return to work.

  1. Data on file.

Patient-Friendly Results

Preserves the Cartilage

Maintains the existing anatomical strength and structural integrity of the septum, without compromising the cartilage.

For All Cartilaginous Deviations

Appropriate for all cartilaginous deviations including the caudal septum.

Maintains Existing Anatomy

Maintains the existing anatomy and structural integrity of the septum.

Fast Patient Recovery

Fast patient recovery (days not weeks) compared to traditional septoplasty.¹

¹ Data on file

Frequently Asked Questions

  • SeptAlign is a new minimally invasive treatment option for correcting a deviated septum. SeptAlign uses a bioresorbable implant that acts like a temporary brace to straighten the septum. The implant holds the septum in its new position, allowing the cartilage memory to reset and maintain the straightened shape.

  • SeptAlign is FDA cleared for all cartilaginous septal deviations and can be used as an adjunct to traditional surgical septoplasty or on patients who are looking for a minimally invasive alternative to traditional septoplasty.

  • SeptAlign is placed using a minimally invasive technique to gently reshape and stabilize the septal cartilage during healing, supporting long-term structural correction.

  • No. SeptAlign is designed to preserve native cartilage and maintain the existing structural integrity of the septum.

  • SeptAlign provides structural support during the healing process and is bioresorbable, dissolving within 6 months.

  • As a recent innovation, SeptAlign is currently available at select sites across the United States, with availability expanding.

  • SeptAlign is designed to support a minimally invasive procedure, with the goal of reducing recovery time compared to traditional septoplasty. In the Vayu clinical study, patients reported a median time to return to work of 1 day when treated with SeptAlign alone or SeptAlign with turbinate reduction.

  • To order, email us at contactus@spirair.com.

  • Contact customer service at customerservice@spirair.com to request a copy of the IFU.

 contact Us

Have Questions About SeptAlign?

Our team is available to provide more information and support physician inquiries about SeptAlign and its clinical applications.

contact us

WEB-001-02